PREVIOUS
✖
India’s 1st needle-free intranasal COVID-19 vaccine
September 10 , 2022
897 days
757
0
- Bharat Biotech has received emergency use authorization for India’s 1st needle-free intranasal COVID-19 vaccine.
- It has been named ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine.
- As of now, the Drug Controller General of India has approved the intranasal vaccine for restricted emergency use in those aged above 18 years.
- The Serum Institute’s COVISHIELD and Bharat Biotech’s COVAXIN were intravenous in nature.
Leave a Reply
Your Comment is awaiting moderation.